Phendimetrazine Yellow Tabs 35mg
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
832 recalls, newest first
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
cGMP deviations
cGMP deviations
Chemical Contamination: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.
CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.
CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.
CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.
CGMP Deviations: Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.
Cross Contamination with other products: trace amounts of lidocaine
Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code.
Superpotent Drug
Superpotent Drug
Superpotent Drug
Failed Impurities/Degradation Specifications: Out of specification result observed in related substance test.
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Lack of Assurance of Sterility; potential loose metal overseal crimp defects.